| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $77.1M | +302.7% |
| R&D Expense | $106.8M | -18.7% |
| SG&A Expense | $89.1M | +50.4% |
| Operating Income | -$131.2M | +24.3% |
| Pre-tax Income | -$142.1M | -69.2% |
| Income Tax | -$6.4M | — |
| Net Income | -$135.7M | -61.5% |
| EPS (Basic) | -$4.01 | -44.8% |
| EPS (Diluted) | -$4.02 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $28.0M | -10.6% |
| Short-term Investments | $123.7M | -1.2% |
| Accounts Receivable | $24.0M | +634.4% |
| Inventory | $5.6M | +267.8% |
| Current Assets | $190.2M | +14.2% |
| Total Assets | $352.9M | +19.8% |
| Current Liabilities | $64.7M | +52.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$120.1M | +9.5% |
| Capital Expenditures | $278K | +1058.3% |
| Investing Cash Flow | $7.7M | -84.1% |
| Financing Cash Flow | $109.1M | +48.5% |
| Free Cash Flow | -$120.4M | +9.3% |
| -45.1% |
| Total Liabilities |
| $210.9M |
| +20.9% |
| Stockholders' Equity | $142.0M | +18.2% |